Current Radiopharmaceuticals,volume 1,issue 3  (01-2008)

Period of time： 2008年3期

Publisher： Bentham Science Publishers

Founded in： 2008

Total resources： 32

E-ISSN： 1874-4729|1|3

ISSN： 1874-4710

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Radiopharmaceuticals,volume 1,issue 3

Menu

Editorial [Hot topic:Targeted Alpha Particle Therapy (Guest Editors: Ganesan Vaidyanathan and Roy Larsen)]

Current Radiopharmaceuticals,volume 1,issue 3 , Vol. 1, Iss. 3, 2008-09 , pp. 125-126

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Commercial Availability of Alpha-Emitting Radionuclides for Medicine

Current Radiopharmaceuticals,volume 1,issue 3 , Vol. 1, Iss. 3, 2008-09 , pp. 127-134

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Production of Alpha Emitters for Targeted Alpha Therapy

Current Radiopharmaceuticals,volume 1,issue 3 , Vol. 1, Iss. 3, 2008-09 , pp. 135-143

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

[211At]Astatine-Labeled Compound Stability: Issues with Released [211At]Astatide and Development of Labeling Reagents to Increase Stability

Current Radiopharmaceuticals,volume 1,issue 3 , Vol. 1, Iss. 3, 2008-09 , pp. 144-176

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Astatine Radiopharmaceuticals: Prospects and Problems

Current Radiopharmaceuticals,volume 1,issue 3 , Vol. 1, Iss. 3, 2008-09 , pp. 177-196

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Experimental Targeted Therapy Using [211At]meta-Astatobenzylguanidine and Transfection of the Noradrenaline Transporter Gene

Current Radiopharmaceuticals,volume 1,issue 3 , Vol. 1, Iss. 3, 2008-09 , pp. 197-202

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy

Current Radiopharmaceuticals,volume 1,issue 3 , Vol. 1, Iss. 3, 2008-09 , pp. 203-208

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Targeted Alpha-Particle Therapy with 227Th-Labeled Antibodies

Current Radiopharmaceuticals,volume 1,issue 3 , Vol. 1, Iss. 3, 2008-09 , pp. 209-214

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Treatment of Diffuse-Type Gastric Cancer Cells Using 213Bi-Radioimmunoconjugates In Vitro and In Vivo Following Intraperitoneal Dissemination

Current Radiopharmaceuticals,volume 1,issue 3 , Vol. 1, Iss. 3, 2008-09 , pp. 215-224

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Targeting EGFR and HER2 with 211At-Labeled Molecules: Unexpected and Expected Dose-Effect Relations in Cultured Tumor Cells

Current Radiopharmaceuticals,volume 1,issue 3 , Vol. 1, Iss. 3, 2008-09 , pp. 225-233

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous 1 2 Next Display item(s) per page Total 13 item(s)